DoD Breast Cancer, Clinical Research Extension Award
Department of Defense
Description
The FY25 Breast Cancer Research Program Clinical Research Extension Award is designed to enhance the impact of breast cancer clinical studies by improving data collection, follow-up, and analysis. This award addresses challenges like early trial termination and limited patient follow-up. Applicants must tackle at least one specified FY25 challenge. Unique aspects include the requirement for research teams to have two or more breast cancer advocates. The funding can support a single Principal…
Summary: The fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) Clinical Research Extension Award aims to extend or expand the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically …
Source
Grant ID
HT942525BCRPCREA2
Agency
Department of Defense
Subcategory/Subagency
Dept. of the Army -- USAMRAA
Eligibility
The following categories of applicants are invited to apply:
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Awards & Funding
Total Funding
$8.4M
Funding Amount
Discretionary
Links
Documents
Similar opportunities
- DoD Breast Cancer Breakthrough Award Level 3
Department of Defense
- DoD Breast Cancer, Breakthrough Award Levels 1 and 2
Department of Defense
- National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
National Institutes of Health
- Forecast to Publish a Funding Opportunity Announcement for Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
Department of Health and Human Services
- NCI Pathway to Independence Award (K99/R00)
National Institutes of Health